ANALGESICS IN FINLAND

Euromonitor International

January 2019

LIST OF CONTENTS AND TABLES

Headlines

Prospects

Discussion of Liberalising Analgesics To New Channels Continues

Added-value Formats and Features Counterbalance the Lowering Effect of Generics

Switched Naproxen and Triptans Likely To Remain Niche Categories

Competitive Landscape

Local Orion Maintains Its Lead Amid Intensifying Competition

Gsk Consumer Healthcare Increases Its Share by Extending Its Portfolio

Lower-cost Vitabalans Oy Actively Develops Its Portfolio

Category Data

Table 1 Sales of Analgesics by Category: Value 2013-2018

Table 2 Sales of Analgesics by Category: % Value Growth 2013-2018

Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2013-2018

Table 4 NBO Company Shares of Analgesics: % Value 2014-2018

Table 5 LBN Brand Shares of Analgesics: % Value 2015-2018

Table 6 Forecast Sales of Analgesics by Category: Value 2018-2023

Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2018-2023

Executive Summary

Health and Wellness Trend and Stressful Lifestyles Drive Consumer Health Sales

the Improving Economy Boosts 2018 Value Sales As Innovative Products Emerge, While Counterbalanced by Intensifying Competition

Consumer Health Remains Fragmented and Players Present Across All Categories Are Rare

Consumer Health Products Are Sold Increasingly Online and in the Grocery Channel

Growth Rates Will Remain Positive, But Slowed Down by Competition and the Maturity of Some Large Categories

Appendix

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and Preventive Medicine

Switches

Summary 1 OTC: Switches

Market Indicators

Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018

Table 9 Life Expectancy at Birth 2013-2018

Market Data

Table 10 Sales of Consumer Health by Category: Value 2013-2018

Table 11 Sales of Consumer Health by Category: % Value Growth 2013-2018

Table 12 NBO Company Shares of Consumer Health: % Value 2014-2018

Table 13 LBN Brand Shares of Consumer Health: % Value 2015-2018

Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2013-2018

Table 15 Distribution of Consumer Health by Format: % Value 2013-2018

Table 16 Distribution of Consumer Health by Format and Category: % Value 2018

Table 17 Forecast Sales of Consumer Health by Category: Value 2018-2023

Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023

Sources

Summary 2 Research Sources

Analgesics can be sold in the pharmacy channel and the online stores of registered pharmacies. Among various organisations, the Finnish Commerce Federation has actively lobbied for the liberalisation of sales of certain OTC products in grocery retailing. The key areas of lobbying have been analgesics and certain dermatological products (such as antipruritics). Naturally, pharmacists have been strongly against this development, but overall the government has hinted that certain OTC products, name...

Euromonitor International's Analgesics in Finland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.